Medicine Classification List




7 MARCH

NEW ZEALAND GAZETTE

containing 0.15% or more of alkaloids calculated as hyoscyamine

  • Sultamicillin; and its salts
  • Sumatriptan; and its salts
  • Tamsulosin hydrochloride
  • Tazobactam
  • T cell receptor antibody
  • Teicoplanin
  • Terazosin; and its salts
  • Terbinafine; except for external use
  • Thymoxamine
  • Tibolone
  • Ticlopidine; and its salts
  • Tinzaparin
  • Tirilazad mesylate
  • Tolrestat
  • Torasemide
  • Trandolapril
  • Trazodone
  • Tretinoin
  • Triptorelin
  • Tropicamide; except when used by a registered optometrist
  • Tropisetron
  • Ursodeoxycholic acid
  • Valaciclovir
  • Venlafaxine
  • Vigabatrin
  • Xamoterol
  • Zalcitabine

Zinc; and its salts; in medicines for internal use containing more than 25 mg of elemental zinc per recommended daily dose

  • Zuclopenthixol; and its salts and esters

Second Schedule

Restricted Medicines

  • Aciclovir; in medicines for external use; except in medicines for ophthalmological use
  • Alcohol, absolute; in medicines for internal and external use, except when compounded in a medicine
  • Aminacrine; and its salts; in medicines for external use
  • Amphotericin; for buccal use
  • Aspirin; in slow-release forms; in enteric-coated forms containing more than 300 mg per dose form
  • Bismuth; and its salts; in medicines for internal use
  • Beta 2 adrenoceptor agonists; except in medicines for inhalation or for parenteral use
  • Carbuterol; and its salts; except in medicines for inhalation or for parenteral use
  • Ciclopirox; for dermatological use in medicines containing more than 1% of ciclopirox
  • Cimetidine; in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing not more than 14 days’ supply
  • Clindamycin; and its salts; in medicines for dermatological use
  • Clotrimazole; in medicines for vaginal use when in pack sizes equivalent to one course of treatment
  • Cholestyramine resin
  • Diclofenac; and its salts; in tablets or capsules containing 25 mg or less and in pack sizes of not more than 30 tablets or capsules
  • Dithranol; and its esters
  • Econazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment
  • Ether; except when used as a vehicle for a topical dose form
  • Ethyl chloride
  • Famotidine; in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing not more than 14 days’ supply and 10 mg or less per dose form
  • Fenoterol; and its salts; except in medicines for inhalation or for parenteral use
  • Glycopyrronium; and its salts; except in medicines for parenteral use
  • Hexoprenaline; and its salts; except in medicines for inhalation or for parenteral use
  • Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 1% or less and no more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container
  • Hydrocortisone; and hydrocortisone acetate; in rectal medicines in cream or ointment form containing 1% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of not more than 35 grams per container
  • Hyoscine; and its salts; in medicines for transdermal use and oral use
  • Hyoscine-N butyl bromide; in medicines for oral use
  • Hyoscyamine; and its salts; in medicines containing 0.15% and less of hyoscyamine; except in forms for parenteral use
  • Ibuprofen; in liquid form for oral use in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing 200 millilitres or less in volume and in strengths of 100 milligrams or less per 5 millilitres
  • Insulins
  • Isoconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment
  • Isoetharine; and its salts; except when contained in medicines for inhalation or for parenteral use
  • Ketoprofen; and its salts; in tablets or capsules containing 25 mg or less of ketoprofen and in pack sizes of not more than 30 tablets or capsules
  • Levocabastine
  • Mercury oxides
  • Mercury, ammoniated
  • Mercury; and its salts; and its compounds
  • Metoclopramide; when compounded with paracetamol and in a pack size of not more than 10 tablets or capsules
  • Miconazole; in medicines for buccal use; and for vaginal use in pack sizes equivalent to one course of treatment
  • Minoxidil; in medicines for external use
  • Mupirocin; and its salts
  • Naproxen; and its salts; in tablets or capsules containing 250 mg or less of naproxen and in pack sizes of not more than 30 tablets or capsules


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 23


NZLII PDF NZ Gazette 1996, No 23





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Medicines, Classification, Prescription, Restricted, Pharmacy-only, General Sale